BEAM - Beam Therapeutics Inc.

QQQ $ 429.07 $ 5.38 (1.28 %)

DIA $ 382.31 $ 3.34 (0.88 %)

SPY $ 505.01 $ 4.68 (0.94 %)

TLT $ 88.87 $ 0.38 (0.43 %)

GLD $ 213.12 $ -0.66 (-0.31 %)

Previous Close

$ 22.72

Open

$ 22.07

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 22.07 - $ 23.05

52 Week Range

$ 16.95 - $ 49.50

Volume

1,056,653

Average Volume

Market Cap

1.75B

Beta (5Y Monthly)

$ 1.26

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-27-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	02-28-2023	12-31-2022	10-K
6	11-07-2022	09-30-2022	10-Q
7	08-09-2022	06-30-2022	10-Q
8	05-09-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	11-08-2021	09-30-2021	10-Q
11	08-10-2021	06-30-2021	10-Q
12	05-11-2021	03-31-2021	10-Q
13	03-15-2021	12-31-2020	10-K
14	11-10-2020	09-30-2020	10-Q
15	08-12-2020	06-30-2020	10-Q
16	05-12-2020	03-31-2020	10-Q
17	03-30-2020	12-31-2019	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Expert Ratings For Beam Therapeutics
04/23/2024 18:00:16

Wedbush Reiterates Outperform on Beam Ther...
04/23/2024 16:32:11

Wedbush analyst David Nierengarten reiterates Beam Therapeutics (NASDAQ:BEAM) with a Outperform and maintains $57 price target.

popular-crypto-trader-shares-2024-predictions-for-these-three-altcoins

Popular Crypto Trader Shares 2024 Predicti...
04/12/2024 17:55:11

Popular pseudonymous crypto analyst Altcoin Sherpa on Friday shared his insights on three altcoins: Beam (CRYPTO: BEAM), Arbitr...

gene-therapy-side-effects-verve-therapeutics-halts-enrollment-of-lead-gene-therapy-trial-in-patients-with-bad-cholesterol

Gene Therapy Side Effects: Verve Therapeut...
04/02/2024 16:19:14

Verve Therapeutics' latest update on the Heart-1 Phase 1b trial of VERVE-101. Explore VERVE-102's development and regul...

Expert Outlook: Beam Therapeutics Through ...
03/27/2024 15:01:00

BMO Capital Maintains Outperform on Beam T...
03/27/2024 14:12:12

BMO Capital analyst Kostas Biliouris maintains Beam Therapeutics (NASDAQ:BEAM) with a Outperform and maintains $57 price tar...

Beam Therapeutics Announces Clearance of C...
03/26/2024 10:31:25

Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, toda...

Navigating 4 Analyst Ratings For Beam Ther...
02/28/2024 15:00:23

RBC Capital Maintains Sector Perform on Be...
02/28/2024 14:58:57

RBC Capital analyst Luca Issi maintains Beam Therapeutics (NASDAQ:BEAM) with a Sector Perform and raises the price target fr...

why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Helix Energy Solutions Shares Are Trad...
02/27/2024 18:18:56

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

norwegian-cruise-line-posts-strong-sales-joins-hims--hers-health-sterling-infrastructure-and-other-big-stocks-moving-higher-on-tuesday

Norwegian Cruise Line Posts Strong Sales, ...
02/27/2024 15:27:54

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.

Recap: Beam Therapeutics Q4 Earnings
02/27/2024 13:25:11

Beam Therapeutics Q4 EPS $1.73 Vs $(0.54) ...
02/27/2024 11:34:24

cathie-wood-trims-nvidia-shopify-stakes-to-pump-whopping-40m-into-pinterest-despite-q4-revenue-miss

Cathie Wood Trims Nvidia, Shopify Stakes T...
02/09/2024 04:49:48

JP Morgan Upgrades Beam Therapeutics to Ov...
01/29/2024 10:43:38

JP Morgan analyst Eric Joseph upgrades Beam Therapeutics (NASDAQ:BEAM) from Neutral to Overweight and raises the price targe...

bitcoin-ethereum-dogecoin-rise-as-investors-weigh-spot-etf-impact-analyst-says-scenario-for-king-crypto-is-rejection-at-46k-and-then-correction-to-below-40k

Bitcoin, Ethereum, Dogecoin Rise As Invest...
01/17/2024 02:50:25

Major cryptocurrencies on Tuesday evening posted some gains following a weekend characterized by

Beam Therapeutics Reports Progress Across ...
01/08/2024 11:39:52

B of A Securities Downgrades Beam Therapeu...
12/15/2023 13:37:54

B of A Securities analyst Greg Harrison downgrades Beam Therapeutics (NASDAQ:BEAM) from Buy to Neutral and announces $35 pri...

Lululemon To Rally Around 14%? Here Are 10...
12/08/2023 12:20:24

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Jefferies Downgrades Beam Therapeutics to ...
12/08/2023 11:56:33

Jefferies analyst Michael Yee downgrades Beam Therapeutics (NASDAQ:BEAM) from Buy to Hold and lowers the price target from $...